Trials / Withdrawn
WithdrawnNCT02621125
Fertilix Supplements and Assisted Reproductive Technology
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- University Reproductive Associates · Academic / Other
- Sex
- Male
- Age
- 20 Years – 55 Years
- Healthy volunteers
- Not accepted
Summary
This is a double blind, randomized, placebo controlled clinical trial to test the efficacy of the antioxidant formulation Fertilix® in lowering the levels of damaged sperm DNA in men diagnosed with moderate to high Sperm Oxidative DNA Damage (SODD)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Fertilix | daily supplementation |
| OTHER | Placebo | Placebo |
Timeline
- Start date
- 2016-02-01
- Primary completion
- 2016-02-01
- Completion
- 2016-02-01
- First posted
- 2015-12-03
- Last updated
- 2017-05-02
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02621125. Inclusion in this directory is not an endorsement.